brequinar has been researched along with dipyridamole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ayres, M; Boytz, R; Chung, D; Davey, RA; Demarest, JF; Gandhi, V; Kienle, M; Kim, EJ; Kumar, VS; Patten, JJ; Pottage, JC; Shohdy, N; Sykes, DB | 1 |
2 other study(ies) available for brequinar and dipyridamole
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.
Topics: Antiviral Agents; Biphenyl Compounds; COVID-19 Drug Treatment; Dipyridamole; Humans; Quinaldines; RNA Viruses; SARS-CoV-2; Virus Replication | 2022 |